Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years
about
Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years
description
scientific article published on 28 March 2019
@en
name
Persistence of Tofacitinib in ...... ension Studies up to 9.5 Years
@en
type
label
Persistence of Tofacitinib in ...... ension Studies up to 9.5 Years
@en
prefLabel
Persistence of Tofacitinib in ...... ension Studies up to 9.5 Years
@en
P2093
P356
P1476
Persistence of Tofacitinib in ...... ension Studies up to 9.5 Years
@en
P2093
Boulos Haraoui
Douglass Chapman
Edward Keystone
Irina Lazariciu
John Woolcott
Lara Fallon
Shahin Jamal
P356
10.1002/ACR2.1010
P50
P577
2019-03-28T00:00:00Z